DocDollars

Eyepoint Us, Inc.

MA · United States · Reporting entity ID 100000316826

Total reported 2019–2025
$24.2M
#285 of 2,960 reporting companies — 0% of all reported industry payments
$3.70M in general payments across 8,871 records, plus $19.1M in research funding across 504 records.

How it breaks down

General payments $3,703,985
Research funding $19,078,637
Ownership & investment $1,426,517

Where this comes from

Figures are from the CMS Open Payments “payments grouped by reporting entity” dataset, queried live. Reporting entities are applicable manufacturers and group purchasing organisations required to report under the Sunshine Act.

Summary

Eyepoint Us, Inc. reported $24.2M to US doctors and teaching hospitals from 2019 to 2025, ranking #285 of 2,960 reporting companies. 79% of that was research funding and 21% general payments such as consulting, speaking, food and travel. 8,871 general payment records and 504 research records were filed.

Common questions about Eyepoint Us, Inc.

How much has Eyepoint Us, Inc. paid US doctors?

Eyepoint Us, Inc. reported $24,209,139 to US physicians and teaching hospitals across the 2019–2025 Open Payments program years: $3,703,985 in general payments, $19,078,637 in research funding and $1,426,517 in ownership and investment interests.

How does Eyepoint Us, Inc. rank among drug and device companies?

It ranks #285 of 2,960 reporting entities by total reported value, about 0% of all industry payments in the dataset.

Does a payment from Eyepoint Us, Inc. mean a doctor did something wrong?

No. Open Payments records transfers of value such as speaking fees, consulting, meals, travel and research funding. The data shows the relationship, not its effect on prescribing or care.